Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes

Archives of Ophthalmology

Volumn 115, Issue 9, 1997, Pages 1137-1141

  Hemdon, Leon V ^a   Choudhri, Saira A ^a   Cox, Terry ^a   Damji, Karim F ^a   Brace Shields, M ^a   Rand Allingham, R ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DORZOLAMIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORNEA THICKNESS; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLIT LAMP; SURFACE TENSION; TONOMETRY; VISUAL ACUITY;

EID: 0030885993     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160307007     Document Type: Article

References (20)

1. Drance SM. The coefficient of scierai rigidity in normal and glaucomatous eyes. Arch Ophthatmol. 1960;63:668-674.
2. Goldmann H, Schmidt T. Über applanationstonometrie. Ophthalmologies. 1957; 134:221-242.
3. Hansen FK, Ehlers N. Elevated tonometer readings caused by a thick cornea. Acta Ophthalmol. 1971;49:775-778.
4. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central comeal thickness. Acta Ophthalmol. 1975;53:34-43.
5. Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol. 1993;115:592-596.
6. Epstein DL, Krug JH, Hertzmark E, Remis LL, Edelstein DJ. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989:96:1460-1467.
7. Kass MA. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial. Trans Am Ophthalmol Soc. 1989;87:598-609.
8. Ehlers N, Hansen FK, Aasved H. Biometrie correlations of corneal thickness. Acta Ophthalmol. 1975;53:652-659.
9. Johnson M, Kass MA, Moses RA, Grodzki WJ. Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol. 1978;96:664-665.
10. Argus WA. Ocular hypertension and central corneal thickness. Ophthalmology. 1995:102:1810-1812.
11. Little RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
12. Goldmann H. Applanation tonometry. In: Newell FW, eds. Glaucoma: Transactions of the Second Conference. New York, NY: Josiah Macy, Jr, Foundation; 1957: 167-220.
13. Hansen FK. A clinical study of the normal human central corneal thickness. Acta Ophthalmol. 1971;49:82-88.
14. Siu A, Herse P. The effect of age on human corneal thickness. Acta Ophthalmol. 1993:71:51-56.
15. Simon G, Small RH, Ren Q, Parel JM. Effect of corneal hydration on Goldmann applanation tonometry and corneal topography. Refractive Corneal Surg. 1993; 9:110-117.
16. Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1993;111:1343-1350.
17. Wang YL, Zhan GL, Toris CB, Yablonski ME. Fluorophotometric study of acetazolamide inhibition of fluid transport across cat corneal endothelium in vivo. Invest Ophthalmol Vis Sei. 1995;36:1385. Abstract.
18. Ehlers N. On corneal thickness and intraocular pressure, II: a clinical study on the thickness of the corneal stroma in glaucomatous eyes. Acta Ophthalmol. 1970; 48:1107-1112.
19. Schipper l, Senn P, Niesen U. Are we measuring the right intraocular pressure after excimer laser photorefractive laser keratoplasty in myopia? Klinische Mon-atsblAugenheilkd. 1995;206:322-324.
20. Chatterjee A, Shah S, Bessant DA, Naroo SA, Doyle SJ. Reduction in intraocular pressure after excimer laser photorefractive keratectomy: correlation with pre-treatment myopia. Ophthalmology. 1997;104:355-359.